| Literature DB >> 30863379 |
Yousef Nami1, Reza Vaseghi Bakhshayesh1, Hossein Mohammadzadeh Jalaly1, Hajie Lotfi1, Solat Eslami1,2, Mohammad Amin Hejazi1.
Abstract
The present study focused on probiotic characterization and safety evaluation of Enterococcus isolates from different artisanal dairy products. All the isolates exhibited inhibitory activity against several food spoilage bacteria and food-borne pathogens, including Shigella flexneri, Staphylococcus aureus, Listeria monocytogenes, Yersinia enterocolitica, Klebsiella pneumoniae, Escherichia coli, and Bacillus subtilis. The PCR results indicated the presence of at least one enterocin structural gene in all the tested strains. The Enterococcus isolates were further evaluated regarding their safety properties and functional features. The isolates were susceptible to vancomycin, gentamycin, and chloramphenicol. The results of PCR amplification revealed that all the tested isolates harbored none of the tested virulence genes except E. faecalis (ES9), which showed the presence of esp gene. The Enterococcus isolates showed cholesterol lowering properties. The selected isolates showed a high tolerance to low pH, and toward bile salts. They also demonstrated hydrophobicity activity, auto-aggregation, and adhesion ability to the human intestinal Caco-2 cell line. These properties may contribute the bacteria colonizing the gut. This study revealed that the Enterococcus isolates, especially E. durans ES11, ES20 and ES32, might be excellent candidates for production of functional foods to promote health benefits.Entities:
Keywords: Enterococcus; Enterococcus as probiotics; antimicrobial activity; dairy products; low cholesterol; probiotic properties; safety evaluation; virulence factors
Year: 2019 PMID: 30863379 PMCID: PMC6400110 DOI: 10.3389/fmicb.2019.00300
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Origin, region of samples prepared, and acid and bile tolerance of isolates.
| Isolates | Origin | Region | Survival rate (%) at pH 2.5 | Survival rate (%) at 0.3% bile |
|---|---|---|---|---|
| ES1 | Cheese | Sarab | 25.1o | 26.6m |
| ES2 | Curd | Ahar | 17.1s | 16.9t |
| ES3 | Yogurt | Kaleybar | 29.2j | 30.2j |
| ES4 | Cheese | Sarab | 69.7d** | 70.1d** |
| ES5 | Yogurt | Heris | 33.2i | 31.1i |
| ES6 | Yogurt | Heris | 15.5u | 14.1w |
| ES7 | Curd | Ahar | 12.6v | 9.1z |
| ES8 | Yogurt | Kaleybar | 34.3h | 36.6f |
| ES9 | Cheese | Kaleybar | 66.2f | 69.1de |
| ES10 | Curd | Ahar | 26.4m | 26.2m |
| ES11 | Cheese | Heris | 76.3c** | 79.8a** |
| ES12 | Curd | Kaleybar | 37.3g | 34.1g |
| ES13 | Yogurt | Sarab | 25.7n | 27.1kl |
| ES14 | Yogurt | Heris | 21.2q | 22.1o |
| ES15 | Cheese | Sarab | 18.2r | 19.1q |
| ES16 | Yogurt | Sarab | 10.3x | 11.2y |
| ES17 | Yogurt | Kaleybar | 17.2s | 18.2r |
| ES18 | Yogurt | Kaleybar | 28.1k | 27.2kl |
| ES19 | Yogurt | Kaleybar | 15.9t | 15.5u |
| ES20 | Cheese | Heris | 81.6a** | 79.1ab** |
| ES21 | Curd | Sarab | 25.3o | 33.1h |
| ES22 | Yogurt | Heris | 27.6l | 24.2n |
| ES23 | Yogurt | Sarab | 11.3w | 12.3x |
| ES24 | Cheese | Kaleybar | 25.2o | 26.4m |
| ES25 | Curd | Ahar | 15.3v | 14.9v |
| ES26 | Yogurt | Heris | 22.2p | 21.4p |
| ES27 | Yogurt | Sarab | 68.4e** | 68.3e** |
| ES28 | Yogurt | Sarab | 68.1c** | 74.3c** |
| ES29 | Curd | Ahar | 18.1s | 17.7s |
| ES30 | Curd | Ahar | 25m | 26.1m |
| ES31 | Cheese | Heris | 26.3kl | 27.1kl |
| ES32 | Yogurt | Heris | 77.4b** | 78.2b** |
Primers used for PCR amplification of virulence factors and enterocin detection genes in Enterococcus strains.
| Gene∗ | Sequence (5′-3′) | Ta (°C) | Amplicon size (bp) | Reference | Enterocin∗∗ | Sequence (5′-3′) | Reference |
|---|---|---|---|---|---|---|---|
| cylA | F: ACTCGGGGATTGATAGGC | 54 | 688 | EntA | F: AAATATTATGGAAATGGAGTGTAT | ||
| clyB | F: ATTCCTACCTATGTTCTGTTA | 56 | 843 | EntB | F: GAAAATGATCACAGAATGCCTA | ||
| esp | F: AGATTTCATCTTTGATTCTTGG | 56 | 510 | EntP | F: TATGGTAATGGTGTTTATTGTAAT | ||
| gelE | F: ACCCCGTATCATTGGTTT | 56 | 402 | EntQ | F: ATGAATTTTCTTCTTAAAAATGGTATCGCA | ||
| asa1 | F: GCACGCTATTACGAACTATGA | 56 | 375 | EntL50A | F: TGGGAGCAATCGCAAAATTAG | ||
| Ace | F: GAATTGAGCAAAAGTTCAATCG | 56 | 320 | EntL50B | F: TGGGAGCAATCGCAAAATTAG | ||
| efaAfs | F: GACAGACCCTCACGAATA | 56 | 705 | Ent1071 | F: CCTATTGGGGGAGAGTCGGT | ||
| cpd | F: TGGTGGGTTATTTTTCAATTC | 50 | 782 | Bac31 | F: TATTACGGAAATGGTTTATATTGT | ||
The inhibitory effect of selected Enterococcus strains against pathogenic microorganisms.
| Isolates | Indicator pathogens | Detection of enterocin structural genes | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EntA | EntB | EntP | EntQ | Ent L50A | Ent L50B | Ent 1071 | Bac 31 | ||||||||
| ES28 | 34.3 ± 0.2 | 22 ± 0.3 | 8.4 ± 0.1 | 8.9 ± 0.2 | 12.9 ± 0.2 | 35.9 ± 0.2 | 33.2 ± 0.2 | + | + | + | - | - | - | - | - |
| ES11 | 30.2 ± 0.1 | – | 13.1 ± 0.2 | 13.1 ± 0.3 | 21.6 ± 0.3 | 23.2 ± 0.2 | 17.5 ± 0.3 | + | + | - | + | + | - | - | - |
| ES32 | 20.3 ± 0.1 | – | 13.1 ± 0.3 | 33.3 ± 0.3 | 27.6 ± 0.3 | 13.4 ± 0.2 | 21.9 ± 0.3 | + | + | - | + | + | - | - | - |
| ES27 | 9.1 ± 0.2 | – | 8.2 ± 0.2 | 13.2 ± 0.3 | 11.2 ± 0.2 | 8.7 ± 0.2 | 7.9 ± 0.2 | + | + | + | - | - | - | - | - |
| ES4 | – | 7.3 ± 0.3 | 9.8 ± 0.3 | – | 22.3 ± 0.2 | 9.3 ± 0.3 | 15.9 ± 0.2 | + | + | + | - | - | - | - | - |
| ES20 | 25 ± 0.1 | 32.4 ± 0.6 | 18.1 ± 0.3 | 17.3 ± 0.2 | 22.2 ± 0.2 | 22.1 ± 0.3 | 26.1 ± 0.2 | + | + | - | + | + | - | - | - |
| ES9 | 22.3 ± 0.2 | – | 17.3 ± 0.2 | 18.5 ± 0.3 | 8.4 ± 0.2 | 13.2 ± 0.2 | 22.2 ± 0.2 | + | + | - | - | - | - | - | - |
The origin of indicator pathogenic bacteria used in this study.
| Indicator pathogens | Culture Collection | Code |
|---|---|---|
| Persian Type Culture Collection (PTCC) | 1234 | |
| American Type Culture Collection (ATCC) | 25923 | |
| American Type Culture Collection (ATCC) | 13932 | |
| American Type Culture Collection (ATCC) | 23715 | |
| Persian Type Culture Collection (PTCC) | 1053 | |
| Persian Type Culture Collection (PTCC) | 1276 | |
| American Type Culture Collection (ATCC) | 19652 | |
FIGURE 1The hydrophobicity, auto-aggregation and adhesion ability of strains to human intestinal cells. a-gMeans in the same color with different lowercase letters differed significantly (p < 0.05).
Origin, Molecular identification, average cholesterol-removal ratio, BSH activity, EPS production, hemolytic activity and β-galactosidase activity of strains after 20 h of growth at 37°C.
| Strain | Molecular identification | Accession number | BSH activity∗ | Assimilated cholesterol rate (μg/mL) | Cholesterol assimilation rate (%) | Haemolytic activity∗∗ | β-galactosidase activity | EPS production∗∗∗ |
|---|---|---|---|---|---|---|---|---|
| ES28 | MK367693 | - | 99.93 | 33.31 | - | - | + | |
| ES11 | MK367694 | +++ | 172.23 | 57.41 | - | + | + | |
| ES32 | JQ366081.1 | +++ | 175.38 | 58.46 | - | + | + | |
| ES27 | JQ366083.1 | ++ | 144.42 | 48.14 | - | + | + | |
| ES4 | JQ366084.1 | + | 145.23 | 48.41 | - | - | + | |
| ES20 | MK367581 | +++ | 216.45 | 72.15 | - | + | + | |
| ES9 | JQ366082.1 | - | 123.63 | 41.21 | - | - | + | |
Co-aggregation (%) of Enterococcus isolates with 7 pathogens during 4 h incubation at 37°C.
| Isolates | Time (hour) | |||||||
|---|---|---|---|---|---|---|---|---|
| ES11 | 2 | 0.9 ± 1.7b | 10.8 ± 0.97b | 11.4 ± 1.18c | 8.1 ± 1.16d | 12.3 ± 1.22d | 13.3 ± 1.98c | 8.1 ± 1.08d |
| ES20 | 6.8 ± 1.25c | 10.9 ± 1.94b | 8.8 ± 1.47d | 11.8 ± 1.67c | 11.9 ± 0.98d | 12.3 ± 0.48c | 10.7 ± 1.26c | |
| ES27 | 1.7 ± 0.32fg | 2.7 ± 0.83g | 1.9 ± 0.51h | 2.1 ± 0.44f | 2.3 ± 0.67g | 2.5 ± 0.36f | 2 ± 0.67h | |
| ES28 | 1.2 ± 0.93g | 3.5 ± 0.91fg | 1.9 ± 0.94h | 6.4 ± 1.27d | 7.3 ± 1.53e | 9.37 ± 1.20d | 1.7 ± 0.64hi | |
| ES32 | 6.7 ± 1.4c | 10.8 ± 0.9b | 7.3 ± 1.2de | 11.4 ± 1.29c | 14.5 ± 1.94c | 12.5 ± 1.25c | 7.9 ± 1.32d | |
| ES4 | 3.7 ± 0.46def | 5.2 ± 1.34ef | 3.9 ± 0.97fg | 4.2 ± 0.81ef | 4.4 ± 0.58fg | 4.7 ± 0.68ef | 4 ± 1.04fg | |
| ES9 | 3.7 ± 0.86def | 6.2 ± 1.1de | 4.3 ± 0.84fg | 6.4 ± 0.88d | 5.9 ± 0.66ef | 6.7 ± 0.75e | 4.7 ± 0.95ef | |
| ES11 | 4 | 12.7 ± 1.3a | 19.9 ± 1.42a | 18.7 ± 1.47a | 14.8 ± 1.23b | 16.7 ± 1.41b | 19.6 ± 1.95b | 13.9 ± 1.77ab |
| ES20 | 10.7 ± 1.8b | 19.5 ± 1.57a | 13.8 ± 1.24b | 21.4 ± 1.58a | 22.6 ± 1.34a | 23.1 ± 2.2a | 14.7 ± 1.09a | |
| ES27 | 2.2 ± 0.25efg | 2.8 ± 0.24g | 2.5 ± 0.34gh | 3.4 ± 0.25f | 3.1 ± 0.42g | 2.9 ± 0.38f | 2.4 ± 0.61gh | |
| ES28 | 4.2 ± 1.65de | 8.5 ± 1.7c | 5.8 ± 1.41ef | 10.7 ± 1.64c | 12.1 ± 1.82d | 12.7 ± 1.69c | 6.4 ± 1.59de | |
| ES32 | 9.9 ± 1.15b | 17.8 ± 1.2a | 11.13 ± 1.4c | 19.7 ± 1.67a | 20.9 ± 1.58a | 19.3 ± 1.38b | 12.4 ± 1.19bc | |
| ES4 | 4.1 ± 0.66de | 5.9 ± 1.29de | 4.3 ± 0.27fg | 6.1 ± 0.98de | 5.7 ± 0.88ef | 5.9 ± 0.62e | 4.4 ± 0.67f | |
| ES9 | 5.2 ± 0.81cd | 7.9 ± 0.82cd | 5 ± 0.64f | 7.7 ± 0.82d | 6.9 ± 1.07e | 9.1 ± 0.82d | 5.7 ± 0.47ef | |
Antibiotic susceptibility of strains.
| Strains | Antibiotic susceptibility)zone of inhibition in mm) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| V | CL | S | FEB | CFM | SXT | K | CP | TE | E | AM | GM | CC | CRO | C | CN | |
| ES28 | S | R | S | S | I | S | I | R | R | I | R | S | S | S | S | S |
| ES11 | S | R | S | S | S | S | S | I | R | S | S | S | S | S | S | S |
| ES32 | S | R | S | S | S | S | S | I | R | S | S | S | S | S | S | S |
| ES27 | S | R | R | R | S | S | S | R | R | S | S | S | R | S | S | R |
| ES4 | S | R | R | S | R | R | S | R | R | S | R | S | R | I | S | R |
| ES20 | S | R | S | S | S | S | S | S | R | S | S | S | S | S | S | S |
| ES9 | S | R | R | R | S | S | I | R | R | I | R | S | R | R | S | R |
FIGURE 2The analysis of the phylogeny of the isolated Enterococcus strains alignment of the sequences was performed with the sequences of different Enterococcus and Lactobacillus species which were submitted in NCBI database as complete sequence.